Morgan Stanley Cuts MetLife (NYSE:MET) Price Target to $93.00

MetLife (NYSE:MET) had its price target decreased by Morgan Stanley from $101.00 to $93.00 in a report issued on Tuesday,Benzinga reports. Morgan Stanley currently has an overweight rating on the financial services provider’s stock.

Other equities research analysts also recently issued reports about the company. UBS Group increased their price objective on MetLife from $94.00 to $98.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Mizuho set a $100.00 target price on shares of MetLife in a research note on Thursday, February 12th. Wells Fargo & Company reduced their price objective on MetLife from $97.00 to $93.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Weiss Ratings upgraded MetLife from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, February 20th. Finally, Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 11th. Two analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, MetLife has an average rating of “Buy” and a consensus price target of $94.18.

MetLife Price Performance

MET stock opened at $72.88 on Tuesday. The stock has a market cap of $47.52 billion, a price-to-earnings ratio of 15.51, a PEG ratio of 0.67 and a beta of 0.76. MetLife has a fifty-two week low of $65.21 and a fifty-two week high of $85.00. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The business has a 50 day moving average price of $77.37 and a 200 day moving average price of $78.76.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, beating analysts’ consensus estimates of $2.34 by $0.15. The firm had revenue of $52.44 billion for the quarter, compared to the consensus estimate of $31.43 billion. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The company’s revenue was up 27.6% on a year-over-year basis. During the same period last year, the firm posted $2.08 EPS. Equities research analysts anticipate that MetLife will post 9.65 earnings per share for the current fiscal year.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd will be issued a $0.5675 dividend. The ex-dividend date is Tuesday, February 3rd. This represents a $2.27 dividend on an annualized basis and a dividend yield of 3.1%. MetLife’s dividend payout ratio is currently 48.30%.

Institutional Investors Weigh In On MetLife

Institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in shares of MetLife by 12.1% in the fourth quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock valued at $5,727,518,000 after purchasing an additional 7,805,814 shares in the last quarter. Dodge & Cox boosted its stake in shares of MetLife by 0.9% during the third quarter. Dodge & Cox now owns 53,659,664 shares of the financial services provider’s stock valued at $4,419,947,000 after acquiring an additional 477,783 shares during the last quarter. Wellington Management Group LLP raised its stake in MetLife by 1.5% in the 3rd quarter. Wellington Management Group LLP now owns 12,572,807 shares of the financial services provider’s stock valued at $1,035,622,000 after purchasing an additional 180,683 shares during the last quarter. Pzena Investment Management LLC boosted its stake in shares of MetLife by 22.9% during the 4th quarter. Pzena Investment Management LLC now owns 11,883,338 shares of the financial services provider’s stock worth $938,071,000 after purchasing an additional 2,211,315 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of MetLife in the second quarter valued at approximately $756,104,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

MetLife News Summary

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife confirmed its previously announced first-quarter 2026 dividend on its Series A floating-rate preferred shares, providing near-term cash-return certainty for preferred holders and removing dividend timing uncertainty. Article Title
• Positive Sentiment: Brokerage coverage remains constructive: a recent note shows MetLife has an average analyst rating of “Buy,” which supports medium-term demand for the stock. Article Title
• Neutral Sentiment: MetLife GCC signed a lease for ~75,000 sq ft in Noida, India — a corporate office move that signals regional investment but is unlikely to materially affect near-term earnings. Article Title
• Neutral Sentiment: MetLife and Crow Holdings completed a trade of 210 multifamily units in Tampa — a routine portfolio transaction that reflects active asset management in its real assets business. Article Title
• Neutral Sentiment: Management presented at the Raymond James institutional investor conference; the transcript provides updated posture on capital deployment and strategy but contained no market-moving surprises. Article Title
• Neutral Sentiment: Media coverage around MetLife Stadium (World Cup match hosting, team training-camp talk) boosts brand visibility but has limited direct impact on insurance fundamentals. Article Title
• Negative Sentiment: Morgan Stanley published a pessimistic forecast on MET stock, which can pressure sentiment and weigh on the share price despite the company’s earnings beat earlier in February. Article Title

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.